• Advancing Breast Cancer Screening with a Non-Invasive Blood Test

    At BCAL Diagnostics, we believe early diagnosis is key to improving breast cancer outcomes. As an Australian and US-based biotechnology company, we are pioneering a non-invasive blood test designed to complement existing breast screening methods and provide women with greater confidence in their results.
    About Us
  • 1 in 7 women

    Will receive a breast cancer diagnosis in their lifetime.

    And BCAL intends to detect her.
    About Us

1 in 7 Women in Australia Will Be Diagnosed with Breast Cancer in their lifetime*

Our Mission 

For over a decade, BCAL Diagnostics has been committed to developing innovative, accessible technologies that enhance breast cancer screening.

Designed to Complement Mammography

Our first-in-class blood test is designed to work
alongside mammography, providing an added layer of screening for women with dense breast tissue. Complementing traditional imaging, the test helps rule out breast cancer, improving diagnostic accuracy and confidence in care.
About BCAL Diagnostics
Jayne Shaw Co-Founder and Executive Chair, Dr John Hurrell Non-Executive Director and Consultant, Shane Ryan Chief Executive Officer

About us

BCAL Diagnostics is led by a team of experts with deep experience in biotechnology, diagnostics, and healthcare innovation. Our leadership is dedicated to advancing scientific excellence and bringing practical, life-changing solutions to improve health outcomes for women.

Dedicated to Advancing Early Detection

BCAL Diagnostics is committed to transforming breast
cancer screening with innovative, non-invasive
diagnostic technology. Our mission is to partner with
clinicians and empower women through early, accurate
breast cancer diagnostics—improving outcomes and
confidence in care.

What we do

BCAL Diagnostics is advancing non-invasive breast cancer screening with a simple blood test designed to complement existing imaging technologies.
About BCAL Diagnostics

Making an Impact

For over a decade, BCAL Diagnostics has been developing a non-invasive diagnostic tool designed to enhance breast cancer screening – resulting in a simple blood test that complements mammography to rule out breast cancer in women over 30 with high breast density. 
Our Reports

Join Our Team in Transforming Breast Cancer Diagnostics

We invite you to take the next step:

Discover how BCAL Diagnostics' blood test is changing the future of breast cancer as part of a comprehensive screening approach.

Discuss our test with your doctor to see if it's right for you.

Support our mission by exploring investment opportunities with BCAL Diagnostics (ASX: BDX).

Contact our team today—we’re here to answer your questions, provide more information, or connect you with the right resources.
Contact Us
Source:
* Breast Cancer Statistics, Breast Cancer Trials est. 2024 figures https://www.breastcancertrials.org.au/breast-cancer-resources/breast-cancer-statistics
Investors
Health Care Professionals
Get Involved
About
hello world!
Subscribe to BCAL
crossmenu